Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.

Source: [CNBC](https://www.cnbc.com/2026/10/02/lilly-novo-amylin-obesity-drugs.html)

Sponsored